Can IGF-I polymorphism affect power and endurance athletic performance?
Introduction
In recent years studies have demonstrated that changes in insulin-like growth factor-I (IGF-I) play a key role in exercise-associated muscle growth and development [1], [2], [3], [4], [5], [6], [7]. Previous studies described that both functional (i.e. maximal oxygen consumption—VO2max) and structural (i.e. thigh muscle volume determined by magnetic resonance images) indices of fitness were correlated with serum IGF-I levels in pre and late pubertal girls [8], [9]. Although casual connections cannot be concluded, these cross-sectional data suggest that fitness in healthy, non-professional, pre-pubertal and adolescent females may be associated with anabolic adaptations of the GH-IGF-I system. Other studies in professional adolescent rhythmic gymnasts demonstrated no difference in circulating IGF-I levels compared to sedentary controls despite reduced adiposity and leptin levels [10]. However, since IGF-I is affected by energy balance, reduced body weight and fat mass is often associated with decreased IGF-I levels. Therefore, the authors suggested that exercise training preserved IGF-I levels in the rhythmic gymnasts. It should be noted that in young females estrogen levels may also influence IGF-I level and IGF-I local skeletal muscle local sensitivity [11]. Similar correlations between fitness and IGF were found among adults as well [12]. Moreover, changes in IGF-I level may be of importance for the skeletal muscle training adaptation, not only for anabolic myofibrillar structure effects, but also for tendons, ligaments, connective tissue and/or bone adaptations [13], [14], [15].
The human gene encoding IGF-I is located on chromosome 12 [16]. The regulatory region of the PI promoter of IGF-I gene is labile [17]. These changes were analyzed in relation to various pathological states [17], [18], [19], [20], [21], [22], [23] but rarely studied in athletes.
C-1245T (rs35767) is a genetic variation in the promoter region of the IGF-I gene, with the T allele being the minor allele. The C-1245T SNP was found to be associated with circulating IGF-I levels, with the minor T allele related to higher circulating IGF-I levels [24], [25], [26]. Along with its relation to elevated resting serum IGF-I, this 192-bp polymorphism (HapMap, http://www.hapmap.org) [27] was found also to be associated with left ventricular hypertrophy (LVH) [20], [28], enhanced response to eccentric arm exercise [29], greater muscle strength response to resistance training [30] and higher bone density [31]. In contrast, the C allele was associated with increased fasting insulin and insulin resistance [32], and the CC genotype was found to be associated with phenotypes that may represent reduced IGF-I function in elderly, mainly African-American, women [33].
Since it is well recognized that the IGF-I gene plays a role in muscle growth and development, it is possible that the IGF-I C-1245T SNP, known to affect serum IGF-I concentration, is one of the polymorphisms that may be related to elite athletic performance. Therefore, the purpose of this study was to analyze the frequency distribution of C-1245T SNP (rs35767) in athletic and nonathletic Israeli populations, and to compare the frequency distribution of the above polymorphism between athletes of sports with different demands (endurance vs. power) as well as between competitive standards (elite vs. national level). We hypothesized that since increased circulating IGF-I may be possibly associated with increased muscle mass, and since muscle mass is more important to power sports, the relatively rare T/T polymorphism will be significantly higher among power athletes.
Section snippets
Participants
One hundred and sixty-five athletes (124 men and 41 women, age: 35.9 ± 12.2 yrs) participated in the study. Athletes were included in the study sample only if they had participated in national/international level competitions. Athletes were divided into two groups: 1) endurance-type group (78 athletes, main sport events ranged from 1500 m run to half Ironman), and 2) power-type group (87 athletes, main sport events were the 100- to 200-m runs and the long jump). According to their individual best
Results
The complete data on allele and genotype frequencies are shown in Table 1. Genotype subtype did not differ by age or sex. In addition, IGF-I C-1245T genotype distribution was in agreement with the Hardy–Weinberg equilibrium within the three groups (P < 0.05). The endurance athletes' allele and genotype frequencies differed markedly from those of the control group (Fig. 1). The power athletes' genotype frequencies differed from those of the control group; however allele frequency did not reach
Discussion
We studied the presence of the C-1245T SNP (rs35767), a nucleotide substitution in the promoter region of the IGF-I gene, in elite endurance and power athletes compared to non-physically active controls. The rare T/T polymorphism was found in 4.8% of the athletes, but was not found at all in the control group participants. In contrast to our hypothesis, the T/T polymorphism was equally distributed among power and endurance athletes.
The effect of C-1245T SNP (rs35767) polymorphism has been
Conflict of interest statement
The authors have nothing to disclose.
References (41)
- et al.
Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice
J. Biol. Chem.
(1995) - et al.
Skeletal muscle IGF-I isoform expression in healthy women after isometric exercise
Growth Horm. IGF Res.
(2006) - et al.
IGF-I is required for normal embryonic growth in mice
Genes Dev.
(1993) - et al.
Insulin-like growth factor-1 prevents age-related decrease in specific force and intracellular Ca2 + in single intact muscle fibres from transgenic mice
J. Physiol.
(2003) - et al.
Cluster analysis tests the importance of myogenic gene expression during myofiber hypertrophy in humans
J. Appl. Physiol.
(2007) - et al.
Exercise training, physical fitness and the growth hormone-insulin-like growth factor-1 axis and cytokine balance
Med. Sport Sci.
(2010) - et al.
Growth hormone-insulin-like growth factor-1 and inflammatory response to a single exercise bout in children and adolescents
Med. Sport Sci.
(2010) - et al.
Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females
J. Clin. Endocrinol. Metab.
(1996) - et al.
Fitness, training, and the growth hormone—insulin-like growth factor I axis in prepubertal girls
J. Clin. Endocrinol. Metab.
(2001) - et al.
Preserved bone health in adolescent elite rhythmic gymnasts despite hypoleptinemia
Horm. Res.
(2007)